文献速递免疫规划卫生政策与健康促进

流感疫苗接种对英格兰流感患者入院后结局的影响:一项基于人群的队列研究

Effect of influenza vaccination on post-admission outcomes for influenza patients in England: a population-based cohort study.
PubMed 文献 · Vaccine · 2025-11-09

该回顾性队列研究利用英国柴郡和默西塞德地区连接初级保健、二级保健和实验室数据的平台,纳入2018年10月至2024年4月2081例≥16岁实验室确诊流感住院成人,分析疫苗接种与住院及出院后结局的关联。结果显示,全队列和≥65岁队列中接种疫苗与住院时间缩短、出院后6个月内死亡风险降低及下一季节接种状态改变相关,未发现重症监护入住或再入院等其他结局的显著差异。

要点

  • ≥16岁、≥65岁和16-64岁人群疫苗接种率分别为38.8%、52.7%和20.9%。
  • 全队列接种者住院时间缩短17%(95%CI 7-26%),≥65岁队列缩短19%(95%CI 7-31%)。
  • 全队列出院后6个月内死亡aHR 0.66(95%CI 0.48-0.90),≥65岁队列aHR 0.67(95%CI 0.48-0.92)。

核心结论

  • 流感疫苗接种与急性病期之外的获益相关,可缩短实验室确诊流感住院成人的住院时间并降低死亡率。
  • 研究结果支持政策决策,包括加强对高风险、低接种率群体的外展服务,并倡导将实验室数据与综合医疗数据 nationally 整合以开展更稳健的疫苗评估。

研究设计与样本

  • 纳入2018年10月至2024年4月2081例≥16岁成人实验室确诊流感住院记录,分析疫苗接种与住院及出院后结局的关联,考虑竞争风险和潜在混杂因素,并进行基于年龄的亚组分析。

主要发现

  • 疫苗接种率在≥16岁、≥65岁和16-64岁人群中分别为38.8%、52.7%和20.9%。
  • 全队列中接种疫苗与住院时间缩短17%(95%CI 7-26%)相关,≥65岁队列中缩短19%(95%CI 7-31%)。
  • 全队列中接种疫苗与出院后6个月内死亡风险降低相关(aHR 0.66,95%CI 0.48-0.90),≥65岁队列中aHR 0.67(95%CI 0.48-0.92)。
  • 全队列中接种疫苗与下一季节接种状态改变相关(aOR 0.19,95%CI 0.13-0.27),≥65岁队列中aOR 0.07(95%CI 0.04-0.13)。
  • 未检测到重症监护入住或再入院、全科就诊、急诊就诊等其他出院后结局的统计学显著差异。

关键数值与推荐

  • 全队列接种者住院时间缩短17%(95%CI 7-26%),≥65岁接种者缩短19%(95%CI 7-31%)。
  • 全队列接种者出院后6个月内死亡aHR 0.66(95%CI 0.48-0.90),≥65岁接种者aHR 0.67(95%CI 0.48-0.92)。
  • 全队列接种者下一季节接种状态改变aOR 0.19(95%CI 0.13-0.27),≥65岁接种者aOR 0.07(95%CI 0.04-0.13)。

临床怎么用

  • 作者认为研究结果支持政策决策,包括加强对高风险、低接种率群体的外展服务。
  • 作者倡导将实验室数据与综合医疗数据 nationally 整合,以开展更稳健的疫苗评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In the UK, adults 65 years and over and those in clinical risk groups are among those eligible for seasonal influenza vaccination. While vaccine effectiveness for reducing cases of influenza is well documented, less is known about impact on wider hospital and post-discharge outcomes in the UK. We investigated whether vaccinated adults hospitalised with confirmed influenza infection had different outcomes to non-vaccinated adults during contact with health services. METHODS: A retrospective cohort study using the Combined Intelligence for Population Health Action platform, linking primary care, secondary care and laboratory data for Cheshire and Merseyside (2.7 M population), UK. We accessed 2081 laboratory-confirmed influenza hospital admissions for adults ≥16 years (October 2018-April 2024). We studied the association of influenza vaccination with several hospital and post-discharge outcomes, considering competing risks and potential confounding factors. We included age-based subgroup analyses. RESULTS: Vaccination uptake was recorded as 38.8 %, 52.7 % and 20.9 % among ≥16, ≥65 and 16-64 years respectively. Among the full cohort and ≥ 65 years cohort, vaccination was associated with a reduction in length of hospital stay in competing risk models (17 %, 95 %CI 7-26 %; 19 %, 95 % CI 7-31 %), risk of death up to six months after discharge (aHR 0.66, 95 %CI 0.48-0.90; aHR 0.67, 95 %CI 0.48-0.92) and change in vaccination status in the next season (aOR 0.19, 95 %CI 0.13-0.27; aOR 0.07 95 %CI 0.04-0.13). No statistically significant difference was detected for admission to critical care or other post-discharge outcomes (readmission, attendance to general practice or emergency department). CONCLUSIONS: Influenza vaccination was associated with benefits beyond acute illness, reducing length of hospital stay and mortality among adults hospitalised with laboratory-confirmed influenza. Findings support policy decisions, including greater outreach to high-risk, low-uptake groups and advocate for the national integration of laboratory data with comprehensive healthcare data to enable more robust vaccine evaluations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jeffery C, Cheyne CP, Buchan I, et al. Effect of influenza vaccination on post-admission outcomes for influenza patients in England: a population-based cohort study. Vaccine. 2025. PMID: 41213184. doi:10.1016/j.vaccine.2025.127933

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。